Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Marker Therapeutics, Inc. (MRKR)
USD1.41
-0.03 (-2.08%)
US NASDAQ Healthcare Biotechnology
Address
3200 Southwest Freeway 77027
Houston, TX, US
Houston, TX, US
CEO
Juan F. Vera
Website
markertherapeutics.com
IPO
2002-07-16
CIK 1094038 ISIN US57055L2060
Description
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company focused on discovering and bringing to market a variety of T cell-based immunotherapies and peptide-based vaccines. These cutting-edge treatments are engineered to address both blood cancers (hematological malignancies) and solid tumor conditions across the United States. A cornerstone of their approach is the proprietary MultiTAA-specific T cell technology. This method involves producing T cells that are not genetically modified but are specifically designed to target tumors. These specialized T cells can identify multiple antigens associated with tumors, allowing them to effectively eliminate cancer cells that express these markers. Marker Therapeutics' MultiTAA-specific T cell therapies encompass patient-derived (autologous) T cells for treating lymphoma and various solid tumors, as well as donor-derived (allogeneic) T cells for acute myeloid leukemia and acute lymphoblastic leukemia. They also provide "off-the-shelf" solutions applicable to a range of diseases. In addition to T cell therapies, the company is advancing peptide-based immunotherapeutic vaccines. This pipeline includes TPIV100/110, developed to combat breast and ovarian cancer cells, and TPIV200, which is currently undergoing Phase 2 clinical trials for the treatment of breast and ovarian cancers. Founded in 1999, Marker Therapeutics maintains its headquarters in Houston, Texas.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.41
-0.03 (-2.08%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
87.9K
Beta
1.45
Float Shares
10.39M
Free Float %
96.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.74% | -3.40% | -14.46% | -2.07% | +48.72% | -4.70% | +25.66% | +8.41% | -94.18% | -97.89% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (5 ratings, all time)
Buy
Price Targets & DCF
Current price
1.41
DCF (Unlevered)
1,049,507.88
+74,433,083.0%
DCF (Levered)
1,049,501.61
+74,432,638.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-35.78
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-46.2% Q1'26: -100.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+33.6% ★ Q1'26: +60.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-361.2%
-
EBIT margin Biotechnology: +0.0%-350.7%
-
ROIC Biotechnology: -16.1%+0.0% ★ Q1'26: +1,455.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+70.5% Q1'26: +73.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2016 actual |
Dec 2018 actual |
Dec 2020 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 10.00M (-100.0%)
|
206.0K
est: 204.0K (+1.0%)
|
466.8K
est: 483.5K (-3.5%)
|
3.51M
est: 9.00M (-61.0%)
|
3.31M
est: 3.73M (-11.2%)
|
6.59M
est: 8.33M (-20.8%)
|
3.55M
est: 3.11M (+14.0%)
|
2.70M
1.10M – 3.99M
-13.4% YoY
|
20.05M
8.20M – 29.69M
+644.0% YoY
|
83.84M
83.84M – 83.84M
+318.1% YoY
|
163.56M
66.89M – 242.14M
+95.1% YoY
|
316.90M
129.60M – 469.16M
+93.8% YoY
|
| EBITDA |
6.04M
est: -10.00M (+160.4%)
|
-147.97M
est: -204.0K (-72,432.4%)
|
-27.63M
est: -483.5K (-5,614.6%)
|
-17.00M
est: -9.00M (-88.9%)
|
-11.79M
est: -3.73M (-216.4%)
|
-11.12M
est: -8.33M (-33.5%)
|
-12.44M
est: -3.11M (-299.8%)
|
-2.70M
-3.99M – -1.10M
+13.4% YoY
|
-20.05M
-29.69M – -8.20M
-644.0% YoY
|
-83.84M
-83.84M – -83.84M
-318.1% YoY
|
-163.56M
-242.14M – -66.89M
-95.1% YoY
|
-316.90M
-469.16M – -129.60M
-93.8% YoY
|
| EBIT |
-2.46M
est: -10.00M (+75.5%)
|
-147.97M
est: -204.0K (-72,432.4%)
|
-28.71M
est: -483.5K (-5,837.1%)
|
-19.79M
est: -9.00M (-119.9%)
|
-14.58M
est: -3.73M (-291.2%)
|
-11.12M
est: -8.33M (-33.5%)
|
-12.44M
est: -3.11M (-299.8%)
|
-2.70M
-3.99M – -1.10M
+13.4% YoY
|
-20.05M
-29.69M – -8.20M
-644.0% YoY
|
-83.84M
-83.84M – -83.84M
-318.1% YoY
|
-163.56M
-242.14M – -66.89M
-95.1% YoY
|
-316.90M
-469.16M – -129.60M
-93.8% YoY
|
| Net Income |
-2.46M
est: -226.30M (+98.9%)
|
-147.96M
est: -96.98M (-52.6%)
|
-28.71M
est: -52.98M (+45.8%)
|
-29.93M
est: -32.33M (+7.4%)
|
-8.24M
est: -10.31M (+20.1%)
|
-10.73M
est: -14.61M (+26.5%)
|
-12.16M
est: -12.16M (+0.0%)
|
-19.54M
-19.57M – -10.75M
-60.6% YoY
|
-19.93M
-25.27M – -3.60M
-2.0% YoY
|
14.78M
-15.72M – 21.98M
+174.2% YoY
|
30.53M
7.07M – 49.60M
+106.6% YoY
|
83.54M
19.35M – 135.72M
+173.6% YoY
|
| SGA |
4.69M
est: 72.85M (-93.6%)
|
24.38M
est: 1.49M (+1,540.5%)
|
10.47M
est: 3.52M (+197.3%)
|
11.34M
est: 65.56M (-82.7%)
|
7.48M
est: 879.63B (-100.0%)
|
4.24M
est: 1.96T (-100.0%)
|
4.18T
est: 734.14B (+470.0%)
|
636.01B
260.11B – 941.57B
-13.4% YoY
|
4.73T
1.94T – 7.01T
+644.0% YoY
|
19.79T
19.79T – 19.79T
+318.1% YoY
|
38.60T
15.79T – 57.14T
+95.1% YoY
|
74.79T
30.59T – 110.72T
+93.8% YoY
|
| EPS |
-3.56
est: -25.20 (+85.9%)
|
-77.50
est: -10.80 (-617.6%)
|
-6.10
est: -5.90 (-3.4%)
|
-3.58
est: -3.60 (+0.6%)
|
-1.93
est: -1.16 (-66.4%)
|
-1.19
est: -0.73 (-63.0%)
|
-0.79
est: -0.53 (-49.0%)
|
-0.99
-1.28 – -0.70
-87.5% YoY
|
-1.02
-1.65 – -0.24
-2.2% YoY
|
0.49
-1.03 – 1.44
+147.7% YoY
|
1.99
0.46 – 3.24
+311.0% YoY
|
5.46
1.26 – 8.86
+173.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-13 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-12.01T
OE per share TTM
-784,721.39
Owner's Yield
-44,421,980.91%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
328.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
15
Total invested
1.25M
Insider transactions (90d)
0
Beneficial owners (>5%)
19
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Centra Holdings, Inc. 46-1957392 | 13.25M | 9.90% | 13.25M | 13.25M | 13.25M | 13.25M | CO | New York | 2013-09-24 | ↗ |
| 2 | Michael Gardner | 5.60M | 7.58% | 5.60M | — | 5.60M | — | IN | United States of America | 2013-01-07 | ↗ |
| 3 | Sailesh C Barchha | 5.60M | 7.58% | — | — | — | — | IN | England | 2013-02-27 | ↗ |
| 4 | Empery Asset Management, LP | 4.64M | 9.90% | — | 4.64M | — | — | PN | Delaware | 2015-01-12 | ↗ |
| 5 | Mark Bruk | 3.90M | 29.80% | 3.90M | 3.90M | 3.90M | 3.90M | IN | Canada | 2000-02-14 | ↗ |
| 6 | Marc Crimeni | 3.60M | 27.50% | 3.60M | 3.60M | 3.60M | 3.60M | IN | Canada | 2000-02-14 | ↗ |
| 7 | Empery Tax Efficient II, LP | 2.87M | 5.20% | — | 2.87M | — | — | PN | Delaware | 2015-01-12 | ↗ |
| 8 | Brio Capital Master Fund Ltd. | 2.76M | 9.99% | 2.76M | — | 2.76M | — | CO | Cayman Islands | 2015-01-12 | ↗ |
| 9 | Joshua Silverman | 2.50M | 9.90% | — | 2.50M | — | — | HC, IN | United States of America | 2016-02-08 | ↗ |
| 10 | Martin D. Hoe | 1.89M | 4.99% | — | 1.89M | — | — | IN | United States | 2015-01-12 | ↗ |
| 11 | Ryan M. Lane | 1.89M | 4.99% | — | 1.89M | — | — | IN | United States | 2015-01-12 | ↗ |
| 12 | Empery Asset Master Ltd. | 1.59M | 8.22% | — | 1.59M | — | — | OO | Cayman Islands | 2014-08-25 | ↗ |
| 13 | American Capital Management L.L.C. | 1.50M | 7.72% | — | 1.50M | — | 1.50M | OO | Delaware | 2015-03-16 | ↗ |
| 14 | Richard Abbe | 272.0K | 7.40% | 63.7K | 208.3K | 63.7K | 208.3K | IN | United States of America | 2018-02-14 | ↗ |
| 15 | Capital Master Fund Ltd. | 237.5K | 0.05% | 237.5K | — | 237.5K | — | CO | Islands | 2019-02-04 | ↗ |
| 16 | Iroquois Capital Management L.L.C. | 208.3K | 5.50% | — | 208.3K | — | 208.3K | OO | Delaware | 2018-02-14 | ↗ |
| 17 | Kimberly Page | 208.3K | 5.50% | — | 208.3K | — | 208.3K | IN | United States of America | 2018-02-14 | ↗ |
| 18 | 0% | — | 0.00% | — | — | — | — | CO | Delaware | 2020-02-14 | ↗ |
| 19 | 10 | — | 0.00% | — | — | — | — | IA | Delaware | 2020-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
15
-21 vs prev Q
New positions
5
Closed positions
26
Increased
6
Reduced
3
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 36.8K +36.8K (+100.0%) | 56.70M +56.7M (+100.0%) | 0.22% +0.220 pp | 0.06% +0.060 pp | USD1.49 +0.0% | 1 qtrs NEW |
| 2 | NEA MANAGEMENT COMPANY, LLC | 1.63M +— (+0.0%) | 2.42M +971.2K (+66.9%) | 9.70% -1.947 pp | 0.12% +0.044 pp | USD1.53 -2.6% | 12 qtrs — |
| 3 | BLUE OWL CAPITAL HOLDINGS LP | 554.3K +— (+0.0%) | 825.8K +331.1K (+66.9%) | 3.31% -0.664 pp | 0.06% -0.092 pp | USD3.11 -52.1% | 5 qtrs — |
| 4 | VANGUARD GROUP INC | 346.1K +46.3K (+15.4%) | 515.7K +247.9K (+92.6%) | 2.07% -0.083 pp | 0.00% +0.000 pp | USD1.73 -13.9% | 12 qtrs — |
| 5 | AISLING CAPITAL MANAGEMENT LP | 325.4K +— (+0.0%) | 484.8K +194.4K (+66.9%) | 1.94% -0.390 pp | 0.10% +0.038 pp | USD3.10 -51.9% | 11 qtrs — |
| 6 | UBS GROUP AG | 174.0K +168.2K (+2,903.6%) | 259.3K +254.1K (+4,911.6%) | 1.04% +0.997 pp | 0.00% +0.000 pp | USD1.47 +1.4% | 12 qtrs — |
| 7 | NEWEDGE ADVISORS, LLC | 149.0K +149.0K (+100.0%) | 222.0K +222.0K (+100.0%) | 0.89% +0.889 pp | 0.00% +0.001 pp | USD1.49 +0.0% | 1 qtrs NEW |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 130.3K +34.0K (+35.3%) | 194.2K +108.3K (+125.9%) | 0.78% +0.088 pp | 0.00% +0.000 pp | USD1.46 +2.1% | 12 qtrs — |
| 9 | RENAISSANCE TECHNOLOGIES LLC | 123.7K +17.4K (+16.4%) | 184.2K +89.4K (+94.3%) | 0.74% -0.023 pp | 0.00% +0.000 pp | USD1.48 +0.7% | 12 qtrs — |
| 10 | TWO SIGMA INVESTMENTS, LP | 98.1K +61.6K (+168.6%) | 146.2K +113.6K (+348.3%) | 0.59% +0.324 pp | 0.00% +0.000 pp | USD1.27 +17.3% | 2 qtrs — |
| 11 | ADVISOR GROUP HOLDINGS, INC. | 94.4K +13.3K (+16.5%) | 140.7K +66.4K (+89.5%) | 0.56% -0.018 pp | 0.00% +0.000 pp | USD1.24 +20.2% | 12 qtrs — |
| 12 | LPL FINANCIAL LLC | 83.2K +24.5K (+41.7%) | 124.0K +71.6K (+136.5%) | 0.50% +0.076 pp | 0.00% +0.000 pp | USD2.63 -43.3% | 5 qtrs — |
| 13 | CITADEL ADVISORS LLC | 58.8K +58.8K (+100.0%) | 87.7K +87.7K (+100.0%) | 0.35% +0.351 pp | 0.00% +0.000 pp | USD1.49 +0.0% | 1 qtrs NEW |
| 14 | XTX TOPCO LTD | 58.0K +36.3K (+166.6%) | 86.5K +67.0K (+345.0%) | 0.35% +0.190 pp | 0.00% +0.001 pp | USD1.27 +17.3% | 2 qtrs — |
| 15 | JANE STREET GROUP, LLC | 40.5K +40.5K (+100.0%) | 60.4K +60.4K (+100.0%) | 0.24% +0.242 pp | 0.00% +0.000 pp | USD1.49 +0.0% | 3 qtrs — |
| 16 | INVST, LLC | 27.0K -2.0K (-6.9%) | 40.2K +14.3K (+55.4%) | 0.16% -0.047 pp | 0.00% +0.001 pp | USD2.28 -34.6% | 6 qtrs — |
| 17 | NORTHERN TRUST CORP | 26.0K +15.2K (+139.6%) | 38.8K +29.1K (+299.9%) | 0.16% +0.077 pp | 0.00% +0.000 pp | USD2.43 -38.7% | 12 qtrs — |
| 18 | STATE STREET CORP | 20.9K +— (+0.0%) | 31.2K +12.5K (+66.9%) | 0.13% -0.025 pp | 0.00% +0.000 pp | USD1.16 +28.4% | 12 qtrs — |
| 19 | CREATIVE PLANNING | 17.3K +— (+0.0%) | 25.8K +10.3K (+66.9%) | 0.10% -0.021 pp | 0.00% +0.000 pp | USD0.71 +109.9% | 12 qtrs — |
| 20 | MATRIX ASSET ADVISORS INC/NY | 15.0K +— (+0.0%) | 22.4K +9.0K (+66.9%) | 0.09% -0.018 pp | 0.00% +0.001 pp | USD1.61 -7.5% | 12 qtrs — |
| 21 | HRT FINANCIAL LP | 13.9K +13.9K (+100.0%) | 20.0K +20.0K (+100.0%) | 0.08% +0.083 pp | 0.00% +0.000 pp | USD1.49 +0.0% | 1 qtrs NEW |
| 22 | ASHTON THOMAS PRIVATE WEALTH, LLC | 10.0K +— (+0.0%) | 14.9K +6.0K (+66.9%) | 0.06% -0.012 pp | 0.00% +0.000 pp | USD0.89 +67.4% | 2 qtrs — |
| 23 | FIFTH THIRD BANCORP | 10.0K +10.0K (+100.0%) | 14.9K +14.9K (+100.0%) | 0.06% +0.060 pp | 0.00% +0.000 pp | USD1.49 +0.0% | 1 qtrs NEW |
| 24 | INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 2.0K +2.0K (+100.0%) | 3.0K +3.0K (+100.0%) | 0.01% +0.012 pp | 0.00% +0.000 pp | USD1.49 +0.0% | 1 qtrs NEW |
| 25 | BANK OF AMERICA CORP /DE/ | 1.1K +3.0 (+0.3%) | 1.7K +677.0 (+67.6%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD1.50 -0.7% | 12 qtrs — |
| 26 | BLACKROCK, INC. | 992.00 +— (+0.0%) | 1.5K +593.0 (+67.0%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD2.82 -47.2% | 6 qtrs — |
| 27 | TOWER RESEARCH CAPITAL LLC (TRC) | 714.00 +714.0 (+100.0%) | 1.1K +1.1K (+100.0%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD1.49 +0.0% | 12 qtrs — |
| 28 | WELLS FARGO & COMPANY/MN | 242.00 +— (+0.0%) | 361.00 +145.0 (+67.1%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.83 +79.5% | 12 qtrs — |
| 29 | SBI SECURITIES CO., LTD. | 203.00 +— (+0.0%) | 302.00 +121.0 (+66.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.54 -3.2% | 5 qtrs — |
| 30 | GROUP ONE TRADING, L.P. | 178.00 +— (+0.0%) | 265.00 +106.0 (+66.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.71 +109.9% | 12 qtrs — |
| 31 | HILLTOP NATIONAL BANK | 73.00 +— (+0.0%) | 109.00 +44.0 (+67.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.52 -2.0% | 3 qtrs — |
| 32 | JPMORGAN CHASE & CO | 23.00 +— (+0.0%) | 34.00 +13.0 (+61.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.96 -24.0% | 11 qtrs — |
| 33 | BNP PARIBAS ARBITRAGE, SNC | 23.00 +— (+0.0%) | 34.00 +13.0 (+61.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.09 -51.8% | 5 qtrs — |
| 34 | MORGAN STANLEY | 15.00 -446.0 (-96.7%) | 22.00 -390.0 (-94.7%) | 0.00% -0.003 pp | 0.00% +0.000 pp | USD2.60 -42.7% | 12 qtrs — |
| 35 | CITIGROUP INC | 6.00 -9.3K (-99.9%) | 9.00 -8.3K (-99.9%) | 0.00% -0.066 pp | 0.00% +0.000 pp | USD0.83 +79.5% | 2 qtrs — |
| 36 | FMR LLC | — -150.0 (-100.0%) | — -134.0 (-100.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD— | 11 qtrs SOLD |
| 37 | TWO SIGMA SECURITIES, LLC | — -47.6K (-100.0%) | — -42.5K (-100.0%) | 0.00% -0.341 pp | 0.00% -0.006 pp | USD— | 2 qtrs SOLD |
| 38 | VERSANT CAPITAL MANAGEMENT, INC | — -15.0 (-100.0%) | — -13.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 12 qtrs SOLD |
| 39 | VIRTU FINANCIAL LLC | — -28.3K (-100.0%) | — -25.0K (-100.0%) | 0.00% -0.203 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 11 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 196.5K | 0.05% |
| 2 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 942.01 | 0.03% |
| 3 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 2.6K | 0.17% |
| 4 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 191.05 | 0.17% |
| 5 | Vanguard Total Stock Market ETF VTI | 0.00% | 442.1K | 0.03% |
| 6 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 969.00 | 0.22% |
| 7 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 527.58 | 0.22% |
| 8 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 213.17 | 0.22% |
| 9 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 23.49 | 0.22% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 3.31 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
8
Sells
0
Shares acquired
1.06M
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+1,062,834
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-17 | Knobil Katharine | Director | A-Award | A | Stock Option (Right to Buy) | 137,330 | 0.95 | 131.1K | 137,330 | D | ↗ |
| 2025-11-17 | Eansor Norman David | Director | A-Award | A | Stock Option (Right to Buy) | 137,330 | 0.95 | 131.1K | 137,330 | D | ↗ |
| 2025-11-17 | ELMS STEVE | Director | A-Award | A | Stock Option (right to buy) | 137,330 | 0.95 | 131.1K | 137,330 | D | ↗ |
| 2025-10-31 | Vera Juan | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 250,000 | 0.99 | 246.9K | 250,000 | D | ↗ |
| 2025-10-31 | Corzo Kathryn Penkus | Director | A-Award | A | Stock Option (Right to Buy) | 147,611 | 0.99 | 145.8K | 147,611 | D | ↗ |
| 2025-02-12 | Vera Juan | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 50,000 | 1.59 | 79.5K | 50,000 | D | ↗ |
| 2025-02-12 | Knobil Katharine | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 1.59 | 47.7K | 30,000 | D | ↗ |
| 2025-02-12 | Eansor Norman David | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 1.59 | 47.7K | 30,000 | D | ↗ |
| 2025-02-12 | ELMS STEVE | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 1.59 | 47.7K | 30,000 | D | ↗ |
| 2024-12-23 | New Enterprise Associates 16, L.P. | 10% Owner | P-Purchase | A | Common Stock | 554,250 | 3.20 | 1.77M | 1,625,678 | D | ↗ |
| 2024-12-23 | ELMS STEVE | Director | P-Purchase | A | Common Stock | 11,085 | 3.20 | 35.5K | 325,370 | I | ↗ |
| 2023-06-30 | Lurier Eliot M | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-06 | Wilson John Robert | Director | A-Award | A | Stock Option (right to buy) | 8,000 | 1.72 | 13.8K | 8,000 | — | ↗ |
| 2023-06-06 | Knobil Katharine | Director | A-Award | A | Stock Option (right to buy) | 8,000 | 1.72 | 13.8K | 8,000 | — | ↗ |
| 2023-06-06 | Eansor Norman David | Director | A-Award | A | Stock Option (right to buy) | 8,000 | 1.72 | 13.8K | 8,000 | — | ↗ |
| 2023-06-06 | ELMS STEVE | Director | A-Award | A | Stock Option (right to buy) | 8,000 | 1.72 | 13.8K | 8,000 | — | ↗ |
| 2023-05-10 | Vera Juan | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 100,000 | 1.42 | 142.0K | 100,000 | — | ↗ |
| 2023-02-27 | Vera Juan | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 46,487 | 2.14 | 99.5K | 46,487 | — | ↗ |
| 2023-02-27 | Szymanska Anna | Officer | A-Award | A | Employee Stock Option (right to buy) | 29,947 | 2.14 | 64.1K | 29,947 | — | ↗ |
| 2023-02-27 | Loiacono Michael | Officer | A-Award | A | Employee Stock Option (right to buy) | 38,480 | 2.14 | 82.3K | 38,480 | — | ↗ |
| 2023-02-27 | Koneru Mythili | Officer | A-Award | A | Employee Stock Option (right to buy) | 51,918 | 2.14 | 111.1K | 51,918 | — | ↗ |
| 2023-02-27 | Hoang Tsvetelina P | Officer | A-Award | A | Employee Stock Option (right to buy) | 33,159 | 2.14 | 71.0K | 33,159 | — | ↗ |
| 2023-02-27 | Agopyan Nadia | Officer | A-Award | A | Employee Stock Option (right to buy) | 34,154 | 2.14 | 73.1K | 34,154 | — | ↗ |
| 2022-05-24 | Wilson John Robert | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 0.00 | — | 80,000 | — | ↗ |
| 2022-05-24 | Laskow-Pooley David | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 0.00 | — | 80,000 | — | ↗ |
| 2022-05-24 | Knobil Katharine | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 0.00 | — | 80,000 | — | ↗ |
| 2022-05-24 | Eansor Norman David | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 0.34 | 27.0K | 80,000 | — | ↗ |
| 2022-05-24 | ELMS STEVE | Director | A-Award | A | Stock Option (Right to Buy) | 80,000 | 0.34 | 27.0K | 80,000 | — | ↗ |
| 2022-03-24 | Vera Juan | Officer | A-Award | A | Common Stock | 140,823 | 0.00 | — | 2,705,310 | — | ↗ |
| 2022-03-24 | Kim Anthony H. | Officer | A-Award | A | Common Stock | 150,512 | 0.00 | — | 150,512 | — | ↗ |
| 2022-03-24 | Hoang Peter L. | Officer | A-Award | A | Common Stock | 199,094 | 0.00 | — | 531,662 | — | ↗ |
| 2022-02-17 | Vera Juan | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 160,000 | 0.46 | 73.6K | 160,000 | — | ↗ |
| 2022-02-17 | Szymanska Anna | Officer | A-Award | A | Employee Stock Option (right to buy) | 40,000 | 0.46 | 18.4K | 40,000 | — | ↗ |
| 2022-02-17 | Loiacono Michael | Officer | A-Award | A | Employee Stock Option (right to buy) | 140,000 | 0.46 | 64.4K | 140,000 | — | ↗ |
| 2022-02-17 | Koneru Mythili | Officer | A-Award | A | Employee Stock Option (right to buy) | 160,000 | 0.46 | 73.6K | 160,000 | — | ↗ |
| 2022-02-17 | Kim Anthony H. | Officer | A-Award | A | Employee Stock Option (right to buy) | 160,000 | 0.46 | 73.6K | 160,000 | — | ↗ |
| 2022-02-17 | Hoang Tsvetelina P | Officer | A-Award | A | Employee Stock Option (right to buy) | 40,000 | 0.46 | 18.4K | 40,000 | — | ↗ |
| 2022-02-17 | Hoang Peter L. | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 430,000 | 0.46 | 197.8K | 430,000 | — | ↗ |
| 2022-02-17 | Garrett Gerald | Officer | A-Award | A | Employee Stock Option (right to buy) | 40,000 | 0.46 | 18.4K | 40,000 | — | ↗ |
| 2022-02-17 | Agopyan Nadia | Officer | A-Award | A | Employee Stock Option (right to buy) | 40,000 | 0.46 | 18.4K | 40,000 | — | ↗ |
| 2021-12-08 | Knobil Katharine | Director | A-Award | A | Stock Option (Right to Buy) | 125,000 | 1.20 | 150.0K | 125,000 | — | ↗ |
| 2021-06-08 | Wilson John Robert | Director | A-Award | A | Common Stock | 12,658 | 0.00 | — | 7,812,008 | — | ↗ |
| 2021-06-08 | Wasserman Frederick Gerald | Director | A-Award | A | Common Stock | 12,658 | 0.00 | — | 65,223 | — | ↗ |
| 2021-06-08 | Laskow-Pooley David | Director | A-Award | A | Common Stock | 12,658 | 0.00 | — | 55,223 | — | ↗ |
| 2021-06-08 | Eansor Norman David | Director | A-Award | A | Common Stock | 12,658 | 0.00 | — | 36,940 | — | ↗ |
| 2021-06-08 | ELMS STEVE | Director | A-Award | A | Common Stock | 12,658 | 0.00 | — | 29,680 | — | ↗ |
| 2021-05-18 | Wasserman Frederick Gerald | Director | P-Purchase | A | Common Stock | 10,000 | 2.41 | 24.1K | 52,565 | — | ↗ |
| 2021-03-25 | Eansor Norman David | Director | G-Gift | A | Common Stock | 7,142 | 0.00 | — | 7,142 | — | ↗ |
| 2021-03-16 | Wilson John Robert | Director | P-Purchase | A | Common Stock | 1,714,285 | 1.75 | 3.00M | 7,799,350 | — | ↗ |
| 2021-03-16 | Walker Paul Edward | 10% Owner | P-Purchase | A | Common Stock | 5,714,285 | 1.75 | 10.00M | 10,714,285 | — | ↗ |
| 2021-03-16 | Vera Juan | Officer | P-Purchase | A | Common Stock | 571,428 | 1.75 | 1,000.0K | 2,564,487 | — | ↗ |
| 2021-03-16 | Sonsini Peter W. | 10% Owner | P-Purchase | A | Common Stock | 5,714,285 | 1.75 | 10.00M | 10,714,285 | — | ↗ |
| 2021-03-16 | SANDELL SCOTT D | 10% Owner | P-Purchase | A | Common Stock | 5,714,285 | 1.75 | 10.00M | 10,714,285 | — | ↗ |
| 2021-03-16 | New Enterprise Associates 16, L.P. | 10% Owner | P-Purchase | A | Common Stock | 5,714,285 | 1.75 | 10.00M | 10,714,285 | — | ↗ |
| 2021-03-16 | Makhzoumi Mohamad | 10% Owner | P-Purchase | A | Common Stock | 5,714,285 | 1.75 | 10.00M | 10,714,285 | — | ↗ |
| 2021-03-16 | MAKOWER JOSHUA | 10% Owner | P-Purchase | A | Common Stock | 5,714,285 | 1.75 | 10.00M | 10,714,285 | — | ↗ |
| 2021-03-16 | Hoang Peter L. | Director / Officer | P-Purchase | A | Common Stock | 142,857 | 1.75 | 250.0K | 332,568 | — | ↗ |
| 2021-03-16 | Florence Anthony A. Jr. | 10% Owner | P-Purchase | A | Common Stock | 5,714,285 | 1.75 | 10.00M | 10,714,285 | — | ↗ |
| 2021-03-16 | Eansor Norman David | Director | P-Purchase | A | Common Stock | 14,285 | 17.50 | 250.0K | 16,713 | — | ↗ |
| 2021-03-16 | ELMS STEVE | Director | P-Purchase | A | Common Stock | 1,142,857 | 1.75 | 2.00M | 3,142,857 | — | ↗ |
| 2021-03-16 | Chang Carmen | 10% Owner | P-Purchase | A | Common Stock | 5,714,285 | 1.75 | 10.00M | 10,714,285 | — | ↗ |
| 2021-03-16 | Behbahani Ali | 10% Owner | P-Purchase | A | Common Stock | 5,714,285 | 1.75 | 10.00M | 10,714,285 | — | ↗ |
| 2021-03-16 | BASKETT FOREST | 10% Owner | P-Purchase | A | Common Stock | 5,714,285 | 1.75 | 10.00M | 10,714,285 | — | ↗ |
| 2021-02-11 | Hoang Peter L. | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 430,000 | 3.06 | 1.32M | 430,000 | — | ↗ |
| 2021-02-10 | Vera Juan | Officer | A-Award | A | Employee Stock Option (right to buy) | 140,000 | 3.29 | 460.6K | 140,000 | — | ↗ |
| 2021-02-10 | Szymanska Anna | Officer | A-Award | A | Employee Stock Option (right to buy) | 40,000 | 3.29 | 131.6K | 40,000 | — | ↗ |
| 2021-02-10 | Loiacono Michael | Officer | A-Award | A | Employee Stock Option (right to buy) | 140,000 | 3.29 | 460.6K | 140,000 | — | ↗ |
| 2021-02-10 | Koneru Mythili | Officer | A-Award | A | Employee Stock Option (right to buy) | 140,000 | 3.29 | 460.6K | 140,000 | — | ↗ |
| 2021-02-10 | Kim Anthony H. | Officer | A-Award | A | Employee Stock Option (right to buy) | 160,000 | 3.29 | 526.4K | 160,000 | — | ↗ |
| 2021-02-10 | Hoang Tsvetelina P | Officer | A-Award | A | Employee Stock Option (right to buy) | 40,000 | 3.29 | 131.6K | 40,000 | — | ↗ |
| 2021-02-10 | Garrett Gerald | Officer | A-Award | A | Employee Stock Option (right to buy) | 40,000 | 3.29 | 131.6K | 40,000 | — | ↗ |
| 2021-02-10 | Agopyan Nadia | Officer | A-Award | A | Employee Stock Option (right to buy) | 40,000 | 3.29 | 131.6K | 40,000 | — | ↗ |
| 2020-12-31 | Wilson John Robert | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-31 | Wasserman Frederick Gerald | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-31 | Laskow-Pooley David | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-31 | Eansor Norman David | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-12-31 | ELMS STEVE | Director | — | I | Common Stock | 0 | 0.00 | — | 2,000,000 | — | ↗ |
| 2020-11-09 | Eastern Capital LTD | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-06-16 | Eastern Capital LTD | 10% Owner | J-Other | D | Series E-1 Warrant | 416,667 | 15.00 | 6.25M | 0 | — | ↗ |
| 2020-03-10 | Vera Juan | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 26,600 | 2.12 | 56.4K | 26,600 | — | ↗ |
| 2020-03-10 | Szymanska Anna | Officer | — | D | Employee Stock Option (Right to Buy) | 60,000 | 4.84 | 290.4K | 0 | — | ↗ |
| 2020-03-10 | Loiacono Michael | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 20,900 | 2.12 | 44.3K | 20,900 | — | ↗ |
| 2020-03-10 | Koneru Mythili | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 23,900 | 2.12 | 50.7K | 23,900 | — | ↗ |
| 2020-03-10 | Kim Anthony H. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 32,500 | 2.12 | 68.9K | 32,500 | — | ↗ |
| 2020-03-10 | Hoang Tsvetelina P | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 14,600 | 2.12 | 31.0K | 14,600 | — | ↗ |
| 2020-03-10 | Hoang Peter L. | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 41,200 | 2.12 | 87.3K | 41,200 | — | ↗ |
| 2020-03-10 | Garrett Gerald | Officer | — | D | Employee Stock Option (Right to Buy) | 200,000 | 3.00 | 600.0K | 0 | — | ↗ |
| 2020-03-10 | Agopyan Nadia | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 7,300 | 2.12 | 15.5K | 7,300 | — | ↗ |
| 2020-02-18 | Eastern Capital LTD | 10% Owner | X-InTheMoney | A | Common Stock | 416,667 | 1.20 | 500.0K | 4,050,001 | — | ↗ |
| 2020-02-15 | Leen Ann M. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-08-15 | Agopyan Nadia | Officer | A-Award | A | Employee Stock Option (right to buy) | 200,000 | 4.80 | 960.0K | 200,000 | — | ↗ |
| 2019-08-14 | Hoang Peter L. | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 4.62 | 46.2K | 189,711 | — | ↗ |
| 2019-08-06 | ELMS STEVE | Director | — | I | Common Stock | 0 | 0.00 | — | 2,000,000 | — | ↗ |
| 2019-05-09 | Wilson John Robert | Director | A-Award | A | Common Stock | 7,260 | 0.00 | — | 6,068,043 | — | ↗ |
| 2019-05-09 | Wasserman Frederick Gerald | Director | A-Award | A | Common Stock | 7,260 | 0.00 | — | 25,543 | — | ↗ |
| 2019-05-09 | Laskow-Pooley David | Director | A-Award | A | Common Stock | 7,260 | 0.00 | — | 25,543 | — | ↗ |
| 2019-05-09 | Koneru Mythili | Officer | — | D | Employee Stock Option (Right to Buy) | 300,000 | 5.10 | 1.53M | 0 | — | ↗ |
| 2019-05-09 | Eansor Norman David | Director | A-Award | A | Common Stock | 7,260 | 0.00 | — | 7,260 | — | ↗ |
| 2018-12-21 | Moseley Ken | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-12-21 | Leen Ann M. | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,993,059 | — | ↗ |
| 2018-12-21 | Hoang Tsvetelina P | Officer | — | I | Employee Stock Option (Right to Buy) | 1,359,855 | 9.18 | 12.48M | 0 | — | ↗ |
| 2018-11-27 | Kim Anthony H. | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 400,000 | 6.81 | 2.72M | 400,000 | — | ↗ |
| 2018-10-19 | Vera Juan | Director | A-Award | A | Employee Stock Option (Right to Buy) | 500,000 | 9.18 | 4.59M | 500,000 | — | ↗ |
| 2018-10-19 | Loiacono Michael | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 300,000 | 9.18 | 2.75M | 300,000 | — | ↗ |
| 2018-10-19 | Hoang Peter L. | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 1,359,855 | 9.18 | 12.48M | 1,359,855 | — | ↗ |
| 2018-10-17 | Wilson John Robert | Director | A-Award | A | Non-Employee Director Stock Option (Right to Buy) | 12,500 | 8.34 | 104.3K | 12,500 | — | ↗ |
| 2018-10-17 | Walker Paul Edward | Director | — | I | Common Stock | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2018-10-17 | Viswanathan Ravi | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2018-10-17 | Vera Juan | Director | — | D | Common Stock | 0 | 0.00 | — | 1,993,059 | — | ↗ |
| 2018-10-17 | Sonsini Peter W. | 10% Owner | — | I | Warrant to Purchase Common Stock (right to buy) | 3,750,000 | 5.00 | 18.75M | 0 | — | ↗ |
| 2018-10-17 | SANDELL SCOTT D | 10% Owner | — | I | Warrant to Purchase Common Stock (right to buy) | 3,750,000 | 5.00 | 18.75M | 0 | — | ↗ |
| 2018-10-17 | New Enterprise Associates 16, L.P. | 10% Owner | — | D | Warrant to Purchase Common Stock (right to buy) | 3,750,000 | 5.00 | 18.75M | 0 | — | ↗ |
| 2018-10-17 | Makhzoumi Mohamad | 10% Owner | — | I | Warrant to Purchase Common Stock (right to buy) | 3,750,000 | 5.00 | 18.75M | 0 | — | ↗ |
| 2018-10-17 | MOTT DAVID M | 10% Owner | — | I | Warrant to Purchase Common Stock (right to buy) | 3,750,000 | 5.00 | 18.75M | 0 | — | ↗ |
| 2018-10-17 | MAKOWER JOSHUA | 10% Owner | — | I | Warrant to Purchase Common Stock (right to buy) | 3,750,000 | 5.00 | 18.75M | 0 | — | ↗ |
| 2018-10-17 | Leen Ann M. | Officer | — | D | Warrants to Acquire Common Stock | 722,783 | 2.99 | 2.16M | 0 | — | ↗ |
| 2018-10-17 | Florence Anthony A. Jr. | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 5,000,000 | — | ↗ |
| 2018-10-17 | Eansor Norman David | Director | A-Award | A | Non-Employee Director Stock Option (Right to Buy) | 12,500 | 8.34 | 104.3K | 12,500 | — | ↗ |
| 2018-10-17 | ELMS STEVE | Director | — | I | Warrant (right to buy) | 1,500,000 | 5.00 | 7.50M | 0 | — | ↗ |
| 2018-10-17 | Chang Carmen | 10% Owner | — | I | Warrant to Purchase Common Stock (right to buy) | 3,750,000 | 5.00 | 18.75M | 0 | — | ↗ |
| 2018-10-17 | Behbahani Ali | Director | — | I | Warrant to Purchase Common Stock (right to buy) | 3,750,000 | 5.00 | 18.75M | 0 | — | ↗ |
| 2018-10-17 | BASKETT FOREST | 10% Owner | — | I | Warrant to Purchase Common Stock (right to buy) | 3,750,000 | 5.00 | 18.75M | 0 | — | ↗ |
| 2018-10-17 | BARRIS PETER J | 10% Owner | — | I | Warrant to Purchase Common Stock (right to buy) | 3,750,000 | 5.00 | 18.75M | 0 | — | ↗ |
| 2018-10-16 | Wasserman Frederick Gerald | Director | A-Award | A | Common Stock | 5,168 | 0.00 | — | 18,283 | — | ↗ |
| 2018-10-16 | Silverman Joshua | Director | A-Award | A | Common Stock | 4,106 | 0.00 | — | 17,221 | — | ↗ |
| 2018-10-16 | Reddish Mark | Director | A-Award | A | Common Stock | 4,106 | 0.00 | — | 36,110 | — | ↗ |
| 2018-10-16 | Laskow-Pooley David | Director | A-Award | A | Common Stock | 5,168 | 0.00 | — | 18,283 | — | ↗ |
| 2018-10-16 | Grisewood Sherry | Director | A-Award | A | Common Stock | 4,106 | 0.00 | — | 19,582 | — | ↗ |
| 2018-10-09 | WILSON GLYNN | Director | A-Award | A | Common Stock | 31,120 | 0.00 | — | 189,337 | — | ↗ |
| 2018-09-22 | WILSON GLYNN | Director | A-Award | A | Common Stock | 31,120 | 0.00 | — | 31,120 | — | ↗ |
| 2018-05-14 | Eastern Capital LTD | 10% Owner | P-Purchase | A | Common Stock | 1,300,000 | 2.40 | 3.12M | 5,300,002 | — | ↗ |
| 2018-02-28 | Silverman Joshua | Director | J-Other | A | Series D Warrants | 41,667 | 9.00 | 375.0K | 41,667 | — | ↗ |
| 2017-09-22 | WILSON GLYNN | Director | A-Award | A | Common Stock | 100,000 | 3.18 | 318.0K | 185,567 | — | ↗ |
| 2017-09-22 | Hoang Peter L. | Director / Officer | A-Award | A | Common Stock | 250,000 | 3.18 | 795.0K | 250,000 | — | ↗ |
| 2017-08-29 | Wasserman Frederick Gerald | Director | A-Award | A | Common Stock | 13,115 | 0.00 | — | 13,115 | — | ↗ |
| 2017-08-29 | Silverman Joshua | Director | A-Award | A | Common Stock | 13,115 | 0.00 | — | 13,115 | — | ↗ |
| 2017-08-29 | Reddish Mark | Director | A-Award | A | Common Stock | 13,115 | 0.00 | — | 32,004 | — | ↗ |
| 2017-08-29 | Laskow-Pooley David | Director | A-Award | A | Common Stock | 13,115 | 0.00 | — | 13,115 | — | ↗ |
| 2017-08-29 | Grisewood Sherry | Director | A-Award | A | Common Stock | 13,115 | 0.00 | — | 15,476 | — | ↗ |
| 2017-03-09 | WILSON GLYNN | Director / Officer | A-Award | A | Common Stock | 12,761 | 0.00 | — | 85,567 | — | ↗ |
| 2017-03-09 | BONFIGLIO JOHN N | Director / Officer | A-Award | A | Common Stock | 5,220 | 0.00 | — | 26,054 | — | ↗ |
| 2016-12-12 | BONFIGLIO JOHN N | Director / Officer | G-Gift | D | Common Stock | 10,417 | 0.00 | — | 20,834 | — | ↗ |
| 2016-11-28 | Silverman Joshua | Director | A-Award | A | Employee Stock Option (Right to Buy) | 12,500 | 4.82 | 60.3K | 12,500 | — | ↗ |
| 2016-08-25 | Loiacono Michael | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 650,000 | 0.48 | 308.8K | 650,000 | — | ↗ |
| 2016-08-10 | Eastern Capital LTD | 10% Owner | J-Other | A | Common Stock | 3,000,000 | 0.60 | 1.80M | 28,000,000 | — | ↗ |
| 2016-07-18 | BONFIGLIO JOHN N | Director / Officer | A-Award | A | Employee Stock Option (Right to Buy) | 750,000 | 0.48 | 356.3K | 1,150,000 | — | ↗ |
| 2016-07-15 | BONFIGLIO JOHN N | Director / Officer | A-Award | A | Common Stock | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2016-01-26 | Wasserman Frederick Gerald | Director | A-Award | A | Employee Stock Option (Right to Buy) | 150,000 | 0.63 | 94.5K | 150,000 | — | ↗ |
| 2015-11-12 | WILSON GLYNN | Director | A-Award | A | Common Stock | 315,000 | 0.61 | 190.6K | 960,457 | — | ↗ |
| 2015-11-12 | Reddish Mark | Director | A-Award | A | Employee Stock Option (Right to Buy) | 150,000 | 0.61 | 90.8K | 154,500 | — | ↗ |
| 2015-11-12 | Grisewood Sherry | Director | A-Award | A | Employee Stock Option (Right to Buy) | 150,000 | 0.61 | 90.8K | 150,000 | — | ↗ |
| 2015-09-09 | Eastern Capital LTD | 10% Owner | X-InTheMoney | D | Series B-1 Warrant | 10,000,000 | 0.20 | 2.00M | 0 | — | ↗ |
| 2015-07-23 | BONFIGLIO JOHN N | Director | A-Award | A | Employee Stock Option (Right to Buy) | 150,000 | 0.57 | 85.5K | 400,000 | — | ↗ |
| 2015-06-16 | Eastern Capital LTD | 10% Owner | X-InTheMoney | A | Common Stock | 5,000,000 | 0.50 | 2.50M | 10,000,000 | — | ↗ |
| 2015-05-28 | Eastern Capital LTD | 10% Owner | J-Other | D | Series B-1 Warrant | 5,000,000 | 0.40 | 2.00M | 0 | — | ↗ |
| 2015-03-19 | Laskow-Pooley David | Director | A-Award | A | Employee Stock Option (Right to Buy) | 150,000 | 0.21 | 31.5K | 150,000 | — | ↗ |
| 2015-03-09 | Eastern Capital LTD | 10% Owner | — | D | Series E-1 Warrant | 5,000,000 | 1.25 | 6.25M | 0 | — | ↗ |
| 2014-12-02 | WILSON GLYNN | Director | A-Award | A | Common Stock | 120,000 | 1.00 | 120.0K | 645,457 | — | ↗ |
| 2014-02-26 | WILSON GLYNN | Director | J-Other | A | Common Stock | 513,319 | 0.80 | 410.7K | 525,457 | — | ↗ |
| 2014-02-26 | Reddish Mark | Director | J-Other | A | Common Stock | 225,000 | 0.80 | 180.0K | 226,667 | — | ↗ |
| 2014-02-26 | Grisewood Sherry | Director | J-Other | A | Common Stock | 28,125 | 0.80 | 22.5K | 28,330 | — | ↗ |
| 2013-03-20 | Grisewood Sherry | Director | — | D | Common Stock | 0 | 0.00 | — | 205 | — | ↗ |
| 2012-04-30 | Reddish Mark | Director | A-Award | A | Employee Stock Option (Right to Buy) | 2,500 | 17.00 | 42.5K | 4,500 | — | ↗ |
| 2012-02-17 | WILSON GLYNN | Director / Officer | J-Other | A | Common Stock | 166,667 | 0.15 | 25.0K | 1,213,726 | — | ↗ |
| 2012-02-17 | Reddish Mark | Officer | — | D | Common Stock | 0 | 0.00 | — | 166,667 | — | ↗ |
| 2012-02-17 | CORIN DENIS | Director / Officer | J-Other | A | Common Stock | 166,667 | 0.15 | 25.0K | 2,394,535 | — | ↗ |
| 2011-03-23 | WILSON GLYNN | Director / Officer | J-Other | A | Common Stock | 147,059 | 0.17 | 25.0K | 1,047,059 | — | ↗ |
| 2011-03-23 | CORIN DENIS | Director / Officer | S-Sale | D | Common Stock | 160,000 | 0.12 | 19.2K | 135,300 | — | ↗ |
| 2011-02-16 | WILSON GLYNN | Director | A-Award | A | Employee Stock Option (Right to Buy | 1,600 | 17.00 | 27.2K | 38,000 | — | ↗ |
| 2011-02-16 | Reddish Mark | Director | A-Award | A | Employee Stock Option (Right to Buy) | 2,000 | 17.00 | 34.0K | 2,000 | — | ↗ |
| 2010-09-07 | DePippo Lynn | Director | — | D | Purchase Options (Under the 2009 Stock Incentive Plan) | 250,000 | 0.17 | 42.5K | 0 | — | ↗ |
| 2009-10-14 | WILSON GLYNN | Director / Officer | A-Award | A | Stock Options | 1,600,000 | 0.97 | 1.55M | 1,640,000 | — | ↗ |
| 2009-10-14 | MOORE TRACY A | Director / Officer | A-Award | A | Stock Options | 500,000 | 0.97 | 485.0K | 500,000 | — | ↗ |
| 2009-10-14 | CORIN DENIS | Director / Officer | A-Award | A | Stock Options | 1,100,000 | 0.97 | 1.07M | 1,180,000 | — | ↗ |
| 2009-08-24 | MOORE TRACY A | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 50,000 | — | ↗ |
| 2009-06-29 | WILSON GLYNN | Director / Officer | J-Other | A | Common stock | 900,000 | 0.10 | 90.0K | 900,000 | — | ↗ |
| 2009-06-29 | CORIN DENIS | Director / Officer | J-Other | A | Common stock | 1,925,750 | 0.10 | 192.6K | 1,933,750 | — | ↗ |
| 2009-03-11 | LINDSAY ALAN P | Director | J-Other | A | Purchase Warrants | 162,000 | 0.01 | 1.6K | 162,000 | — | ↗ |
| 2009-03-11 | CORIN DENIS | Officer | J-Other | A | Purchase Warrants | 200,000 | 0.01 | 2.0K | 350,000 | — | ↗ |
| 2009-02-04 | CORIN DENIS | Director / Officer | A-Award | A | Purchase Warrants | 14,458 | 2.00 | 28.9K | 54,458 | — | ↗ |
| 2008-06-30 | CORIN DENIS | Officer | J-Other | D | Option to buy | 1,000,000 | 0.32 | 320.0K | 800,000 | — | ↗ |
| 2008-06-24 | CORIN DENIS | Officer | J-Other | A | Option to buy | 1,000,000 | 0.32 | 320.0K | 1,800,000 | — | ↗ |
| 2007-06-08 | WILSON GLYNN | Director | — | D | OPTIONS | 200,000 | 0.25 | 50.0K | 0 | — | ↗ |
| 2007-06-08 | MCGOWAN PATRICK A | Director / Officer | — | D | COMMON SHARES | 0 | 0.00 | — | 181,432 | — | ↗ |
| 2007-06-08 | LINDSAY ALAN P | Director | — | I | COMMON SHARES | 0 | 0.00 | — | 566,664 | — | ↗ |
| 2007-06-08 | Jefferies Wilfred Arthur | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,443,716 | — | ↗ |
| 2007-06-08 | CORIN DENIS | Officer | — | D | COMMON SHARES | 0 | 0.00 | — | 110,000 | — | ↗ |
| 2004-08-30 | Konstantine Sarafis | Officer | — | D | Common Stock Options | 100,000 | 0.50 | 50.0K | 0 | — | ↗ |
| 2004-06-30 | Farrauto Edward | Officer | — | I | Common Stock Options | 100,000 | 0.70 | 70.0K | 0 | — | ↗ |
| 2003-12-31 | JEFFERIES WILFRED | Director / Officer / 10% Owner | A-Award | A | Stock Options | 0 | 1.00 | — | 500,000 | — | ↗ |
| 2003-12-31 | HANDFORD RONALD L | Director / Officer / 10% Owner | A-Award | A | Warrent | 0 | 0.75 | — | 8,000 | — | ↗ |
| 2003-12-16 | PEARSON TERRY W DR | Director | — | D | Stock Options | 100,000 | 1.00 | 100.0K | 0 | — | ↗ |
| 2003-12-16 | MACKINNON NORMAN J R C A | Director | — | D | Stock Options | 25,000 | 1.00 | 25.0K | 0 | — | ↗ |
| 2003-12-16 | JEFFERIES WILFRED | Director / Officer / 10% Owner | A-Award | A | Stock Options | 1,500,000 | 0.50 | 750.0K | 1,500,000 | — | ↗ |
| 2003-12-16 | HANDFORD RONALD L | Director / Officer / 10% Owner | A-Award | A | Stock Options | 200,000 | 0.50 | 100.0K | 200,000 | — | ↗ |
| 2003-12-16 | ATKINS GRANT R | Director / Officer | A-Award | A | Stock Options | 250,000 | 0.50 | 125.0K | 250,000 | — | ↗ |
| 2003-12-16 | ATKINS GRANT | Director / Officer | A-Award | A | Stock Options | 250,000 | 0.50 | 125.0K | 250,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-24.9K
Shares Outstanding
10.80M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Juan Vera, President and Chief Executive Officer | 415.4K | — | — | 266.0K | — | — | 741.2K | 35.89% | ↗ |
| 2 | 2024 | Juan Vera, President and Chief Executive Officer | 400.0K | — | — | — | — | — | 400.0K | 0.00% | ↗ |
| 3 | 2023 | Peter Hoang, Former President and Chief Executive Officer | 156.9K | — | — | — | — | 425.5K | 582.4K | 0.00% | ↗ |
| 4 | 2023 | Juan Vera, President and Chief Executive Officer | 399.3K | — | — | 186.0K | — | — | 581.9K | 31.96% | ↗ |
| 5 | 2023 | Michael Loiacono, former Chief Accounting Officer | 175.9K | — | — | 63.0K | — | 327.6K | 566.5K | 11.12% | ↗ |
| 6 | 2023 | Mythili Koneru, our Former Chief Medical Officer | 135.3K | — | — | 84.8K | — | — | 220.1K | 38.52% | ↗ |
| 7 | 2022 | Anthony Kim Former Chief Financial Officer | 330.4K | — | — | 52.8K | — | 546.0K | 929.2K | 5.68% | ↗ |
| 8 | 2022 | Mythili Koneru, our Former Chief Medical Officer | 424.3K | — | — | 52.8K | 155.3K | — | 632.4K | 8.35% | ↗ |
| 9 | 2022 | Mythili Koneru Former Chief Medical Officer | 424.3K | — | — | 52.8K | 155.3K | — | 632.4K | 8.35% | ↗ |
| 10 | 2022 | Juan Vera, President and Chief Executive Officer | 380.0K | — | — | 52.8K | 149.1K | — | 581.9K | 9.07% | ↗ |
| 11 | 2022 | Juan Vera President and Chief Executive Officer | 380.0K | — | — | 52.8K | 149.1K | — | 581.9K | 9.07% | ↗ |
| 12 | 2022 | Peter Hoang Former President and Chief Executive Officer | 424.3K | — | — | 141.9K | — | — | 566.2K | 25.06% | ↗ |
| 13 | 2022 | Peter Hoang, Former President and Chief Executive Officer | 424.3K | — | — | 141.9K | — | — | 556.2K | 25.51% | ↗ |
| 14 | 2022 | Michael Loiacono, former Chief Accounting Officer | 314.4K | — | — | 46.0K | 118.7K | — | 479.2K | 9.60% | ↗ |
| 15 | 2021 | Peter Hoang President and Chief Executive Officer | 424.1K | — | — | 1.00M | 193.0K | — | 1.62M | 61.88% | ↗ |
| 16 | 2021 | Peter Hoang Former President and Chief Executive Officer | 424.1K | — | — | 1.00M | 193.0K | — | 1.62M | 61.88% | ↗ |
| 17 | 2021 | Anthony Kim Chief Financial Officer | 400.8K | — | — | 401.6K | 145.9K | — | 948.3K | 42.35% | ↗ |
| 18 | 2021 | Anthony Kim Former Chief Financial Officer | 400.8K | — | — | 401.6K | 145.9K | — | 948.3K | 42.35% | ↗ |
| 19 | 2021 | Mythili Koneru Former Chief Medical Officer | 405.8K | — | — | 351.4K | 144.3K | — | 901.5K | 38.98% | ↗ |
| 20 | 2021 | Mythili Koneru Chief Medical Officer | 405.8K | — | — | 351.4K | 144.3K | — | 901.5K | 38.98% | ↗ |
| 21 | 2020 | Peter Hoang President and Chief Executive Officer | 416.9K | — | — | 748.2K | 209.0K | — | 1.37M | 54.45% | ↗ |
| 22 | 2020 | Anthony Kim Chief Financial Officer | 392.9K | — | — | 278.4K | 158.0K | — | 829.3K | 33.57% | ↗ |
| 23 | 2020 | Mythili Koneru Chief Medical Officer | 398.6K | — | — | 243.6K | 140.0K | — | 782.2K | 31.14% | ↗ |
| 24 | 2019 | Mythili Koneru Chief Medical Officer | 313.5K | 50.0K | — | 1.44M | 41.6K | — | 1.84M | 78.03% | ↗ |
| 25 | 2019 | Peter Hoang President and Chief Executive Officer | 380.0K | — | — | — | 71.7K | — | 451.7K | 0.00% | ↗ |
| 26 | 2019 | Anthony Kim Chief Financial Officer | 375.0K | — | — | — | 56.5K | — | 431.5K | 0.00% | ↗ |
| 27 | 2018 | Peter Hoang CEO and President | 362.5K | 181.3K | — | 12.47M | — | — | 13.01M | 95.82% | ↗ |
| 28 | 2018 | Peter Hoang President and Chief Executive Officer | 362.5K | — | — | 12.47M | 181.3K | — | 13.01M | 95.82% | ↗ |
| 29 | 2018 | Michael J. Loiacono Chief Accounting Officer and Principal Accounting Officer and Corporate Secretary Former Officer: | 213.0K | 75.0K | — | 2.75M | — | — | 3.04M | 90.52% | ↗ |
| 30 | 2018 | Anthony Kim Chief Financial Officer | 28.8K | — | — | 2.72M | — | — | 2.77M | 97.88% | ↗ |
| 31 | 2017 | Peter Hoang CEO and President | 90.6K | 11.3K | 795.0K | — | — | — | 896.9K | 88.64% | ↗ |
| 32 | 2017 | Glynn Wilson | 261.3K | 25.6K | 318.0K | — | — | — | 604.9K | 52.57% | ↗ |
| 33 | 2017 | Michael J. Loiacono Chief Accounting Officer and Principal Accounting Officer and Corporate Secretary Former Officer: | 200.0K | 30.0K | — | — | — | — | 230.0K | 0.00% | ↗ |
| 34 | 2016 | John Bonfiglio President and Chief Operating Officer | 115.0K | 45.0K | 102.5K | 374.9K | — | 100.6K | 738.0K | 64.69% | ↗ |
| 35 | 2016 | Glynn Wilson Chairman, CEO and President | 276.2K | 110.0K | 191.0K | — | — | 49.2K | 626.4K | 30.49% | ↗ |
| 36 | 2016 | Michael J. Loiacono Chief Financial Officer, Chief Accounting Officer and Principal Accounting Officer | 66.9K | 10.0K | — | 308.7K | — | 21.6K | 407.2K | 75.81% | ↗ |
| 37 | 2015 | Glynn Wilson Chairman, CEO and President | 204.0K | — | — | 605.0K | — | 11.0K | 820.0K | 73.78% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Juan F. Vera | Co-Founder, Chief Executive Officer, President, Treasurer, Secretary & Director | 415.4K | — |
| Elizabeth Donnelly | Director of Administration | — | female |
| Edmund Cheung | Vice President of Human Resources | — | male |
| Mary Newman | Head of Regulatory Affairs | — | female |
| Patricia Allison | Head of Clinical Operations | — | — |
| Robert Z. Florkiewicz | Senior Director of Molecular Biology & Virology | — | — |
| Maria-Bernadette Madel | Director of Corporate Operations & External Communications | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MRKR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
